Literature DB >> 15647839

Van Der Woude syndrome: variable penetrance of a novel mutation (p.Arg 84Gly) of the IRF6 gene in a Turkish family.

Chike Bellarmine Item1, Dritan Turhani, Dietmar Thurnher, Kaan Yerit, Klaus Sinko, Gert Wittwer, Wasiu Lanre Adeyemo, Klemens Frei, Nihan Erginel-Unaltuna, Franz Watzinger, Rolf Ewers.   

Abstract

Van der Woude syndrome (VWS) is an autosomal dominant disorder characterized by clefts of the lip and/or palate (CL+/-P), lip pits, bifid uvula and hypodontia. Mutations of the interferon regulatory factor 6 gene (IRF6) have been recently described in patients with VWS. The entire 9 exons of the IRF6 gene in two brothers of Turkish origin clinically diagnosed with Van der Woude syndrome and four healthy family members were screened for mutations using a newly established denaturing gradient gel electrophoresis (DGGE) method. A novel heterozygous mutation in exon 2 (DNA binding region) of the IRF6 gene, p.Arg84Gly, was found in both brothers with VWS and in their clinically asymptomatic mother. Our results suggest a dominant negative effect of the p.Arg84Gly mutation in the VWS of both patients. Non-penetrance of this mutation is suggested in the mother of the patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647839

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  IRF6 Screening of Syndromic and a priori Non-Syndromic Cleft Lip and Palate Patients: Identification of a New Type of Minor VWS Sign.

Authors:  L Desmyter; M Ghassibe; N Revencu; O Boute; M Lees; G François; C Verellen-Dumoulin; Y Sznajer; A Moncla; H Benateau; K Claes; K Devriendt; M Mathieu; L Van Maldergem; M-C Addor; V Drouin-Garraud; G Mortier; M Bouma; A Dieux-Coeslier; D Genevieve; A Goldenberg; A Gozu; P Makrythanasis; U McEntagart; A Sanchez; C Vilain; S Vermeer; F Connell; J Verheij; S Manouvrier; G Pierquin; S Odent; M Holder-Espinasse; C Vincent-Delorme; Y Gillerot; R Vanwijck; B Bayet; M Vikkula
Journal:  Mol Syndromol       Date:  2010-06-09

Review 2.  Toward an orofacial gene regulatory network.

Authors:  Youssef A Kousa; Brian C Schutte
Journal:  Dev Dyn       Date:  2015-09-17       Impact factor: 3.780

3.  Van der Woude syndrome: a review of 11 cases seen at the Lagos University Teaching Hospital.

Authors:  Olutayo James; Wasiu L Adeyemo; Christian I Emeka; Mobolanle O Ogunlewe; Akinola L Ladeinde; Azeez Butali
Journal:  Afr J Paediatr Surg       Date:  2014 Jan-Mar

4.  Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndrome.

Authors:  Renata L L Ferreira de Lima; Sarah A Hoper; Michella Ghassibe; Margaret E Cooper; Nicholas K Rorick; Shinji Kondo; Lori Katz; Mary L Marazita; John Compton; Sherri Bale; Ute Hehr; Michael J Dixon; Sandra Daack-Hirsch; Odile Boute; Bénédicte Bayet; Nicole Revencu; Christine Verellen-Dumoulin; Miikka Vikkula; Antônio Richieri-Costa; Danilo Moretti-Ferreira; Jeffrey C Murray; Brian C Schutte
Journal:  Genet Med       Date:  2009-04       Impact factor: 8.822

5.  Missense mutations that cause Van der Woude syndrome and popliteal pterygium syndrome affect the DNA-binding and transcriptional activation functions of IRF6.

Authors:  Hayley J Little; Nicholas K Rorick; Ling-I Su; Clair Baldock; Saimon Malhotra; Tom Jowitt; Lokesh Gakhar; Ramaswamy Subramanian; Brian C Schutte; Michael J Dixon; Paul Shore
Journal:  Hum Mol Genet       Date:  2008-11-26       Impact factor: 6.150

6.  Novel IRF6 mutations in families with Van Der Woude syndrome and popliteal pterygium syndrome from sub-Saharan Africa.

Authors:  Azeez Butali; Peter A Mossey; Wasiu L Adeyemo; Mekonen A Eshete; LauRen A Gaines; Dee Even; Ramat O Braimah; Babatunde S Aregbesola; Jennifer V Rigdon; Christian I Emeka; Olutayo James; Mobolanle O Ogunlewe; Akinola L Ladeinde; Fikre Abate; Taye Hailu; Ibrahim Mohammed; Paul E Gravem; Milliard Deribew; Mulualem Gesses; Adebowale A Adeyemo; Jeffrey C Murray
Journal:  Mol Genet Genomic Med       Date:  2014-01-27       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.